NO307459B1 - Piperazinderivater, samt farmasøytiske preparater inneholdende slike - Google Patents
Piperazinderivater, samt farmasøytiske preparater inneholdende slikeInfo
- Publication number
- NO307459B1 NO307459B1 NO963792A NO963792A NO307459B1 NO 307459 B1 NO307459 B1 NO 307459B1 NO 963792 A NO963792 A NO 963792A NO 963792 A NO963792 A NO 963792A NO 307459 B1 NO307459 B1 NO 307459B1
- Authority
- NO
- Norway
- Prior art keywords
- well
- pharmaceutical preparations
- preparations containing
- piperazine derivatives
- piperazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19950000399 | 1995-01-11 | ||
| KR1019950043607A KR0162710B1 (ko) | 1995-01-10 | 1995-11-24 | 신규 피페라진 유도체 및 그 제조방법 |
| PCT/KR1996/000005 WO1996021648A1 (en) | 1995-01-11 | 1996-01-10 | New piperazine derivatives and methods for the preparation thereof and compositions containing the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO963792D0 NO963792D0 (no) | 1996-09-10 |
| NO963792L NO963792L (no) | 1996-11-11 |
| NO307459B1 true NO307459B1 (no) | 2000-04-10 |
Family
ID=26630862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO963792A NO307459B1 (no) | 1995-01-11 | 1996-09-10 | Piperazinderivater, samt farmasøytiske preparater inneholdende slike |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5780472A (ja) |
| EP (1) | EP0749425A1 (ja) |
| JP (1) | JP2978967B2 (ja) |
| CN (1) | CN1128139C (ja) |
| AU (1) | AU699619B2 (ja) |
| BR (1) | BR9605309A (ja) |
| CA (1) | CA2184919C (ja) |
| CZ (1) | CZ288002B6 (ja) |
| FI (1) | FI963566A (ja) |
| HU (1) | HUP9602489A3 (ja) |
| NO (1) | NO307459B1 (ja) |
| NZ (1) | NZ298499A (ja) |
| PL (1) | PL183865B1 (ja) |
| RO (1) | RO115159B1 (ja) |
| SK (1) | SK282252B6 (ja) |
| WO (1) | WO1996021648A1 (ja) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0755923B1 (en) * | 1995-01-23 | 2005-05-04 | Daiichi Suntory Pharma Co., Ltd. | Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor |
| PL325341A1 (en) * | 1996-06-29 | 1998-07-20 | Samjin Pharmaceutical Co | Derivatives od piperazine and method of obtaining them |
| US6794392B1 (en) | 1996-09-30 | 2004-09-21 | Schering Aktiengesellschaft | Cell differentiation inducer |
| US6174905B1 (en) * | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
| KR100420616B1 (ko) * | 1996-12-26 | 2004-05-17 | 동화약품공업주식회사 | 신규테레프탈산아미드유도체 |
| AU754529B2 (en) | 1998-09-22 | 2002-11-21 | Yamanouchi Pharmaceutical Co., Ltd. | Cyanophenyl derivatives |
| AU763030B2 (en) * | 1999-03-03 | 2003-07-10 | Samjin Pharmaceutical Co., Ltd. | Piperazine derivatives and process for the preparation thereof |
| US6723730B2 (en) | 2000-07-20 | 2004-04-20 | Neurogen Corporation | Capsaicin receptor ligands |
| DE10035908A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| US6432957B1 (en) * | 2001-06-29 | 2002-08-13 | Kowa Co., Ltd. | Piperazine derivative |
| EP1421071B1 (en) * | 2001-07-02 | 2009-11-18 | High Point Pharmaceuticals, LLC | Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
| CZ2004519A3 (cs) * | 2001-10-22 | 2004-12-15 | Pfizer Products Inc. | Deriváty piperazinu s účinky antagonisty receptoru CCR1 |
| CZ2004714A3 (cs) * | 2001-12-14 | 2004-10-13 | Novoánordiskáa@S | Sloučeniny a jejich použití ke snížení aktivity lipázy citlivé vůči hormonu |
| JP4583760B2 (ja) | 2002-02-01 | 2010-11-17 | ユーロ−セルティーク エス．エイ． | 疼痛の治療に有用な治療薬 |
| EA200500114A1 (ru) | 2002-06-28 | 2005-06-30 | Еуро-Селтик, С. А. | Терапевтические агенты, используемые для лечения боли |
| US7262194B2 (en) | 2002-07-26 | 2007-08-28 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| US7157462B2 (en) * | 2002-09-24 | 2007-01-02 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| JP4960085B2 (ja) * | 2003-03-19 | 2012-06-27 | エクセリクシス， インク． | Ｔｉｅ−２モジュレータと使用方法 |
| ME02222B (me) | 2004-12-30 | 2016-02-20 | Janssen Pharmaceutica Nv | Amid derivati piperidin-i piperazin-1-karboksilne kiseline te povezani spojevi kao modulatori amid hidrolaze masnih kiselina (faah) za liječenje tjeskobe, boli i drugih stanja |
| KR101063663B1 (ko) | 2005-02-17 | 2011-09-07 | 아스텔라스세이야쿠 가부시키가이샤 | 피리딜 비방향족 질소 함유 헤테로환-1-카르복실산에스테르유도체 |
| WO2007005510A1 (en) | 2005-06-30 | 2007-01-11 | Janssen Pharmaceutica N.V. | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase |
| CA2618653A1 (en) | 2005-08-12 | 2007-02-22 | Takeda Pharmaceutical Company Limited | Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| MX2009004233A (es) | 2006-10-18 | 2009-08-12 | Pfizer Prod Inc | Compuestos de biaril eter urea. |
| WO2008148851A1 (en) | 2007-06-08 | 2008-12-11 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
| CA2687754C (en) | 2007-06-08 | 2015-12-08 | Janssen Pharmaceutica N.V. | Piperidine, piperazine derivatives for use as dgat inhibitors |
| AU2008258549B2 (en) | 2007-06-08 | 2013-11-14 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
| JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
| MX2010003918A (es) * | 2007-10-10 | 2010-08-04 | Takeda Pharmaceutical | Compuesto de amida. |
| WO2009147170A2 (en) | 2008-06-05 | 2009-12-10 | Janssen Pharmaceutica Nv | Drug combinations comprising a dgat inhibitor and a ppar-agonist |
| US20120225097A1 (en) | 2009-11-12 | 2012-09-06 | Hawryluk Natalie A | Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah) |
| UA108233C2 (uk) * | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
| WO2017083216A1 (en) * | 2015-11-12 | 2017-05-18 | Merck Sharp & Dohme Corp. | Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use |
| US11970486B2 (en) * | 2016-10-24 | 2024-04-30 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| WO2019084157A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES THEREOF |
| WO2022118966A1 (ja) * | 2020-12-04 | 2022-06-09 | 国立大学法人京都大学 | 細胞内への核酸分子取り込み促進剤、医薬組成物、及び新規化合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| OA04700A (fr) * | 1973-05-15 | 1980-07-31 | Rhone Poulenc Sa | Nouveaux dérivés de la naphtyridine et leur procédé de préparation. |
| AU7580187A (en) * | 1986-06-23 | 1988-01-12 | Upjohn Company, The | Androstane-type and cortical aminoesters |
| US4960776A (en) * | 1987-01-28 | 1990-10-02 | A. H. Robins Company, Inc. | 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides |
| JPH02142770A (ja) * | 1988-11-25 | 1990-05-31 | Shigeki Shin | ピペラジン系誘導体 |
| JPH03141258A (ja) * | 1989-10-25 | 1991-06-17 | Kowa Co | 新規なピペラジン誘導体 |
| DE4216364A1 (de) * | 1991-12-14 | 1993-11-25 | Thomae Gmbh Dr K | Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US5196428A (en) * | 1992-04-03 | 1993-03-23 | Bristol-Myers Squibb Company | Imidazo[4,5-b]qinolinyl oxy alkyl ureas |
-
1996
- 1996-01-10 PL PL96316613A patent/PL183865B1/pl unknown
- 1996-01-10 WO PCT/KR1996/000005 patent/WO1996021648A1/en not_active Application Discontinuation
- 1996-01-10 HU HU9602489A patent/HUP9602489A3/hu unknown
- 1996-01-10 US US08/676,174 patent/US5780472A/en not_active Expired - Lifetime
- 1996-01-10 CN CN96190006A patent/CN1128139C/zh not_active Expired - Lifetime
- 1996-01-10 EP EP96900459A patent/EP0749425A1/en not_active Withdrawn
- 1996-01-10 BR BR9605309A patent/BR9605309A/pt unknown
- 1996-01-10 SK SK889-96A patent/SK282252B6/sk unknown
- 1996-01-10 JP JP8521570A patent/JP2978967B2/ja not_active Expired - Lifetime
- 1996-01-10 RO RO96-01781A patent/RO115159B1/ro unknown
- 1996-01-10 CA CA002184919A patent/CA2184919C/en not_active Expired - Lifetime
- 1996-01-10 CZ CZ19962960A patent/CZ288002B6/cs not_active IP Right Cessation
- 1996-01-10 AU AU44007/96A patent/AU699619B2/en not_active Expired
- 1996-01-10 NZ NZ298499A patent/NZ298499A/en not_active IP Right Cessation
- 1996-09-10 NO NO963792A patent/NO307459B1/no unknown
- 1996-09-10 FI FI963566A patent/FI963566A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9602489A2 (en) | 1997-08-28 |
| CA2184919C (en) | 2000-03-14 |
| PL183865B1 (pl) | 2002-07-31 |
| HUP9602489A3 (en) | 1998-01-28 |
| US5780472A (en) | 1998-07-14 |
| WO1996021648A1 (en) | 1996-07-18 |
| NZ298499A (en) | 1998-01-26 |
| JP2978967B2 (ja) | 1999-11-15 |
| CN1128139C (zh) | 2003-11-19 |
| EP0749425A1 (en) | 1996-12-27 |
| JPH09511764A (ja) | 1997-11-25 |
| SK88996A3 (en) | 1997-05-07 |
| HU9602489D0 (en) | 1996-11-28 |
| RO115159B1 (ro) | 1999-11-30 |
| SK282252B6 (sk) | 2001-12-03 |
| AU699619B2 (en) | 1998-12-10 |
| FI963566A0 (fi) | 1996-09-10 |
| CN1145620A (zh) | 1997-03-19 |
| AU4400796A (en) | 1996-07-31 |
| CA2184919A1 (en) | 1996-07-18 |
| BR9605309A (pt) | 1997-10-14 |
| NO963792D0 (no) | 1996-09-10 |
| PL316613A1 (en) | 1997-01-20 |
| CZ296096A3 (en) | 1997-02-12 |
| FI963566A (fi) | 1996-09-10 |
| CZ288002B6 (cs) | 2001-03-14 |
| NO963792L (no) | 1996-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO307459B1 (no) | Piperazinderivater, samt farmasøytiske preparater inneholdende slike | |
| NO965377D0 (no) | Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene | |
| NO973923D0 (no) | Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene | |
| DE69615376D1 (de) | Piperazin-derivate als heilmittel | |
| NO944700D0 (no) | Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene | |
| ATE226819T1 (de) | Arzneizubereitungen für piperidinalkanolderivate | |
| NO179911C (no) | Optisk aktivt 5H-pyrrolo[3,4-bÅpyrazinderivat samt farmasöytiske preparater inneholdende derivatet | |
| DE69831620D1 (de) | Arzneizubereitungen enthaltend Kannabinoide | |
| NL300214I1 (nl) | Chinazolinederivaten. | |
| NO982580L (no) | Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene | |
| NO180584C (no) | Bisnaftalimider som inneholder aminosyreavledete linkere, for anvendelse som antikreftmidler, samt farmasöytiske preparater | |
| TR199600883A2 (tr) | Pürin-6-on türevleri. | |
| NO308287B1 (no) | Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse | |
| NO951283D0 (no) | Nye taxanderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene | |
| BR9610214A (pt) | Compostos farmacéuticos | |
| FI941447A0 (fi) | Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet | |
| NO982874D0 (no) | Farmas°ytiske preparater med vitamin D-analoger | |
| NO942910L (no) | Nye baccatin-III- og 10-desacetyl-baccatin-III-derivater, deres fremstillinger, samt farmasöytiske preparater inneholdende derivatene | |
| TR199600715A2 (tr) | Kefalosforin türevleri. | |
| NO974563D0 (no) | Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene | |
| FI973230A (fi) | Uusi farmaseuttinen formulaatio | |
| TR199600064A2 (tr) | 4-amino-benzoilguanidin-türevleri. | |
| TR199601018A1 (tr) | Farmasötik bilesikler. | |
| NO951679L (no) | Fibronektin-bindende protein, samt fremstilling derav | |
| NO951350D0 (no) | Farmasöytiske preparater inneholdende 3-substituerte 2-oksindol-1-karboksamider |